padsevonil (UCB0942) / UCB 
Welcome,         Profile    Billing    Logout  
  Diseases    Trials    Trials    News 
1 Trials

   

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
padsevonil (UCB0942) / UCB
ChiCTR2000041476: A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED SINGLE-DOSE STUDY TO EVALUATE THE PHARMACOKINETICS, SAFETY, AND TOLERABILITY OF PADSEVONIL IN HEALTHY CHINESE SUBJECTS

Recruiting
1
14
 
Padsevonil(PSL) 200 mg ;placebo
West China Hospital, Sichuan University; UCB Biopharma SPRL, UCB Biopharma SPRL
epilepsy
 
 

Download Options